North Carolina is a hot spot for gene therapy. The state is currently home to many university driven gene therapy startups, more than 1,800 clinical trials, 120 CRO/CDMOs, and 200 manufacturing firms. In just five years, the North Carolina gene therapy market is booming and is expected to grow 5x by 2026.
So what makes North Carolina great for gene therapy? Our experts from Sarepta, Novartis Gene Therapy, Beam Therapeutics, Audentes Therapeutics, and North Carolina Biotechnology Center will discuss the emergence of the state’s gene therapy ecosystem and share their predictions for the future of the industry.